Analysis of the innate and adaptive phases of allograft rejection by cluster analysis of transcriptional profiles

被引:38
作者
Christopher, K [1 ]
Mueller, TF [1 ]
Ma, CY [1 ]
Liang, YR [1 ]
Perkins, DL [1 ]
机构
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Lab Mol Immunol, Boston, MA 02115 USA
关键词
D O I
10.4049/jimmunol.169.1.522
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Both clinical and experimental observations suggest that allograft rejection is a complex process with multiple components that are, at least partially, functionally redundant. Studies using graft recipients deficient in various genes including chemokines, cytokines, and other immune-associated genes frequently produce a phenotype of delayed, but not indefinitely prevented, rejection. Only a small subset of genetic deletions (for example, TCRalpha or beta, MHC I and 11, B7-1 and B7-2, and recombinase-activating gene) permit permanent graft acceptance suggesting that rejection is orchestrated by a complex network of interrelated inflammatory and immune responses. To investigate this complex process, we have used oligonucleotide microarrays to generate quantitative mRNA expression profiles following transplantation. Patterns of gene expression were confirmed with real-time PCR data. Hierarchical clustering algorithms clearly differentiated the early and late phases of rejection. Self-organizing maps identified clusters of coordinately regulated genes. Genes up-regulated during the early phase included genes with prior biological functions associated with ischemia, injury, and Ag-independent innate immunity, whereas genes up-regulated in the late phase were enriched for genes associated with adaptive immunity.
引用
收藏
页码:522 / 530
页数:9
相关论文
共 61 条
[1]   Hepatic expression of macrophage inflammatory protein-1 alpha and macrophage inflammatory protein-1 beta after liver transplantation [J].
Adams, DH ;
Hubscher, S ;
Fear, J ;
Johnston, J ;
Shaw, S ;
Afford, S .
TRANSPLANTATION, 1996, 61 (05) :817-825
[2]   RISK-FACTORS FOR CHRONIC REJECTION IN RENAL-ALLOGRAFT RECIPIENTS [J].
ALMOND, PS ;
MATAS, A ;
GILLINGHAM, K ;
DUNN, DL ;
PAYNE, WD ;
GORES, P ;
GRUESSNER, R ;
NAJARIAN, JS ;
FERGUSON ;
PAUL ;
SCHAFFER .
TRANSPLANTATION, 1993, 55 (04) :752-757
[3]   PROTEASOME SUBUNITS ENCODED IN THE MHC ARE NOT GENERALLY REQUIRED FOR THE PROCESSING OF PEPTIDES BOUND BY MHC CLASS-I MOLECULES [J].
ARNOLD, D ;
DRISCOLL, J ;
ANDROLEWICZ, M ;
HUGHES, E ;
CRESSWELL, P ;
SPIES, T .
NATURE, 1992, 360 (6400) :171-174
[4]   Cellular responses to interferon-gamma [J].
Boehm, U ;
Klamp, T ;
Groot, M ;
Howard, JC .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :749-795
[5]   SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury [J].
Bradshaw, AD ;
Sage, EH .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (09) :1049-1054
[6]   Anti-rejection prophylaxis by blocking selectin dependent cell adhesion after rat allogeneic and xenogeneic lung transplantation [J].
Brandt, M ;
Derner, G ;
Boeke, K ;
Phillips, ML ;
Steinhoff, G ;
Haverich, A .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1997, 12 (05) :781-786
[7]   EXPRESSION OF SGP-1 MESSENGER-RNA IN PREIMPLANTATION MOUSE EMBRYOS [J].
CAO, QP ;
CRAIN, WR .
DEVELOPMENTAL GENETICS, 1995, 17 (03) :263-271
[8]  
CAUGHEY GH, 1991, J BIOL CHEM, V266, P12956
[9]  
CECKA JM, 1999, CLIN TRANSPLANTS 199
[10]  
CECKA JM, 2000, CLIN TRANSPL, V1